nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Fluid overload—Carboplatin—testicular cancer	0.0538	0.0693	CcSEcCtD
Terlipressin—Skin necrosis—Ifosfamide—testicular cancer	0.0326	0.042	CcSEcCtD
Terlipressin—Skin necrosis—Cisplatin—testicular cancer	0.0281	0.0362	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—INSL3—testicular cancer	0.0258	0.115	CbGpPWpGaD
Terlipressin—Skin necrosis—Etoposide—testicular cancer	0.0257	0.0331	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—INSL3—testicular cancer	0.025	0.112	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—INSL3—testicular cancer	0.0179	0.0799	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—INSL3—testicular cancer	0.0177	0.0794	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.0173	0.0774	CbGpPWpGaD
Terlipressin—Fluid overload—Cisplatin—testicular cancer	0.0158	0.0203	CcSEcCtD
Terlipressin—Skin necrosis—Methotrexate—testicular cancer	0.0154	0.0198	CcSEcCtD
Terlipressin—Ventricular fibrillation—Ifosfamide—testicular cancer	0.0149	0.0191	CcSEcCtD
Terlipressin—Skin necrosis—Epirubicin—testicular cancer	0.0144	0.0186	CcSEcCtD
Terlipressin—Skin necrosis—Doxorubicin—testicular cancer	0.0133	0.0172	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—INSL3—testicular cancer	0.0132	0.0589	CbGpPWpGaD
Terlipressin—Skin exfoliation—Bleomycin—testicular cancer	0.0127	0.0164	CcSEcCtD
Terlipressin—Cyanosis—Etoposide—testicular cancer	0.0127	0.0164	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Ifosfamide—testicular cancer	0.0126	0.0162	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.012	0.0536	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.0119	0.0532	CbGpPWpGaD
Terlipressin—Respiratory failure—Ifosfamide—testicular cancer	0.0116	0.0149	CcSEcCtD
Terlipressin—Skin exfoliation—Ifosfamide—testicular cancer	0.0109	0.014	CcSEcCtD
Terlipressin—Pulmonary oedema—Ifosfamide—testicular cancer	0.0101	0.013	CcSEcCtD
Terlipressin—Skin exfoliation—Cisplatin—testicular cancer	0.00937	0.0121	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—INSL3—testicular cancer	0.00913	0.0408	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—INSL3—testicular cancer	0.00906	0.0405	CbGpPWpGaD
Terlipressin—Atrial fibrillation—Ifosfamide—testicular cancer	0.00872	0.0112	CcSEcCtD
Terlipressin—Acute coronary syndrome—Vinblastine—testicular cancer	0.00869	0.0112	CcSEcCtD
Terlipressin—Myocardial infarction—Vinblastine—testicular cancer	0.00865	0.0111	CcSEcCtD
Terlipressin—Skin exfoliation—Etoposide—testicular cancer	0.00858	0.0111	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00847	0.0379	CbGpPWpGaD
Terlipressin—Cardiac failure—Ifosfamide—testicular cancer	0.00847	0.0109	CcSEcCtD
Terlipressin—Cyanosis—Methotrexate—testicular cancer	0.00761	0.0098	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—INSL3—testicular cancer	0.00744	0.0333	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Bleomycin—testicular cancer	0.00734	0.00946	CcSEcCtD
Terlipressin—Myocardial infarction—Bleomycin—testicular cancer	0.0073	0.0094	CcSEcCtD
Terlipressin—Hyponatraemia—Cisplatin—testicular cancer	0.00715	0.00921	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—INSL3—testicular cancer	0.00676	0.0302	CbGpPWpGaD
Terlipressin—Cardiac failure—Etoposide—testicular cancer	0.00669	0.00861	CcSEcCtD
Terlipressin—Acute coronary syndrome—Ifosfamide—testicular cancer	0.00628	0.00808	CcSEcCtD
Terlipressin—Myocardial infarction—Ifosfamide—testicular cancer	0.00624	0.00804	CcSEcCtD
Terlipressin—Hypertension—Vinblastine—testicular cancer	0.00595	0.00766	CcSEcCtD
Terlipressin—Bradycardia—Ifosfamide—testicular cancer	0.00582	0.00749	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Epirubicin—testicular cancer	0.00558	0.00718	CcSEcCtD
Terlipressin—Respiratory failure—Methotrexate—testicular cancer	0.00548	0.00706	CcSEcCtD
Terlipressin—Acute coronary syndrome—Cisplatin—testicular cancer	0.00541	0.00697	CcSEcCtD
Terlipressin—Myocardial infarction—Cisplatin—testicular cancer	0.00538	0.00693	CcSEcCtD
Terlipressin—Cardiac disorder—Ifosfamide—testicular cancer	0.0053	0.00683	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.0053	0.00683	CcSEcCtD
Terlipressin—Angiopathy—Ifosfamide—testicular cancer	0.00519	0.00668	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—testicular cancer	0.00516	0.00665	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—INSL3—testicular cancer	0.00516	0.0231	CbGpPWpGaD
Terlipressin—Skin exfoliation—Methotrexate—testicular cancer	0.00514	0.00662	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—INSL3—testicular cancer	0.00512	0.0229	CbGpPWpGaD
Terlipressin—Bradycardia—Cisplatin—testicular cancer	0.00502	0.00646	CcSEcCtD
Terlipressin—Malnutrition—Ifosfamide—testicular cancer	0.00498	0.00641	CcSEcCtD
Terlipressin—Acute coronary syndrome—Etoposide—testicular cancer	0.00496	0.00638	CcSEcCtD
Terlipressin—Chest pain—Bleomycin—testicular cancer	0.00496	0.00638	CcSEcCtD
Terlipressin—Myocardial infarction—Etoposide—testicular cancer	0.00493	0.00635	CcSEcCtD
Terlipressin—Abdominal pain—Chlorambucil—testicular cancer	0.00485	0.00625	CcSEcCtD
Terlipressin—Skin exfoliation—Epirubicin—testicular cancer	0.00481	0.0062	CcSEcCtD
Terlipressin—Pulmonary oedema—Methotrexate—testicular cancer	0.00479	0.00617	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—INSL3—testicular cancer	0.00468	0.021	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—INSL3—testicular cancer	0.00465	0.0208	CbGpPWpGaD
Terlipressin—Cardiac disorder—Cisplatin—testicular cancer	0.00457	0.00589	CcSEcCtD
Terlipressin—Pulmonary oedema—Epirubicin—testicular cancer	0.00448	0.00578	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—testicular cancer	0.00445	0.00573	CcSEcCtD
Terlipressin—Abdominal pain—Vinblastine—testicular cancer	0.00445	0.00573	CcSEcCtD
Terlipressin—Hypertension—Ifosfamide—testicular cancer	0.0043	0.00553	CcSEcCtD
Terlipressin—Malnutrition—Cisplatin—testicular cancer	0.00429	0.00552	CcSEcCtD
Terlipressin—Dyspnoea—Bleomycin—testicular cancer	0.00424	0.00546	CcSEcCtD
Terlipressin—Chest pain—Ifosfamide—testicular cancer	0.00424	0.00546	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00421	0.00542	CcSEcCtD
Terlipressin—Diarrhoea—Chlorambucil—testicular cancer	0.0042	0.00541	CcSEcCtD
Terlipressin—Cardiac disorder—Etoposide—testicular cancer	0.00419	0.0054	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—testicular cancer	0.00415	0.00534	CcSEcCtD
Terlipressin—Angiopathy—Etoposide—testicular cancer	0.0041	0.00527	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—INSL3—testicular cancer	0.00399	0.0179	CbGpPWpGaD
Terlipressin—Nervous system disorder—Ifosfamide—testicular cancer	0.00398	0.00513	CcSEcCtD
Terlipressin—Skin disorder—Ifosfamide—testicular cancer	0.00394	0.00508	CcSEcCtD
Terlipressin—Hot flush—Epirubicin—testicular cancer	0.00391	0.00504	CcSEcCtD
Terlipressin—Vomiting—Chlorambucil—testicular cancer	0.0039	0.00503	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—testicular cancer	0.00388	0.00499	CcSEcCtD
Terlipressin—Diarrhoea—Vinblastine—testicular cancer	0.00385	0.00496	CcSEcCtD
Terlipressin—Cardiac failure—Epirubicin—testicular cancer	0.00375	0.00483	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—testicular cancer	0.00367	0.00473	CcSEcCtD
Terlipressin—Nausea—Chlorambucil—testicular cancer	0.00365	0.0047	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00363	0.00467	CcSEcCtD
Terlipressin—Dyspnoea—Ifosfamide—testicular cancer	0.00362	0.00466	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—testicular cancer	0.00362	0.00466	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—testicular cancer	0.00359	0.00462	CcSEcCtD
Terlipressin—Vomiting—Vinblastine—testicular cancer	0.00358	0.00461	CcSEcCtD
Terlipressin—Headache—Vinblastine—testicular cancer	0.00352	0.00454	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00351	0.00451	CcSEcCtD
Terlipressin—Abdominal pain—Dactinomycin—testicular cancer	0.0035	0.00451	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—testicular cancer	0.00347	0.00447	CcSEcCtD
Terlipressin—Nervous system disorder—Cisplatin—testicular cancer	0.00343	0.00442	CcSEcCtD
Terlipressin—Tachycardia—Cisplatin—testicular cancer	0.00342	0.0044	CcSEcCtD
Terlipressin—Skin disorder—Cisplatin—testicular cancer	0.0034	0.00438	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—testicular cancer	0.0034	0.00438	CcSEcCtD
Terlipressin—Hypertension—Etoposide—testicular cancer	0.00339	0.00437	CcSEcCtD
Terlipressin—Chest pain—Etoposide—testicular cancer	0.00335	0.00431	CcSEcCtD
Terlipressin—Nausea—Vinblastine—testicular cancer	0.00334	0.0043	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00332	0.00428	CcSEcCtD
Terlipressin—Abdominal pain—Ifosfamide—testicular cancer	0.00321	0.00413	CcSEcCtD
Terlipressin—Tachycardia—Etoposide—testicular cancer	0.00313	0.00403	CcSEcCtD
Terlipressin—Dyspnoea—Cisplatin—testicular cancer	0.00312	0.00402	CcSEcCtD
Terlipressin—Skin disorder—Etoposide—testicular cancer	0.00312	0.00401	CcSEcCtD
Terlipressin—Diarrhoea—Dactinomycin—testicular cancer	0.00303	0.0039	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00302	0.00389	CcSEcCtD
Terlipressin—Vomiting—Bleomycin—testicular cancer	0.00302	0.00389	CcSEcCtD
Terlipressin—Dyspnoea—Etoposide—testicular cancer	0.00286	0.00368	CcSEcCtD
Terlipressin—Nausea—Bleomycin—testicular cancer	0.00282	0.00363	CcSEcCtD
Terlipressin—Vomiting—Dactinomycin—testicular cancer	0.00282	0.00363	CcSEcCtD
Terlipressin—Diarrhoea—Ifosfamide—testicular cancer	0.00278	0.00358	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00277	0.00357	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—INSL3—testicular cancer	0.00277	0.0124	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—INSL3—testicular cancer	0.00275	0.0123	CbGpPWpGaD
Terlipressin—Nausea—Dactinomycin—testicular cancer	0.00263	0.00339	CcSEcCtD
Terlipressin—Vomiting—Ifosfamide—testicular cancer	0.00258	0.00333	CcSEcCtD
Terlipressin—Bradycardia—Epirubicin—testicular cancer	0.00258	0.00332	CcSEcCtD
Terlipressin—Abdominal pain—Etoposide—testicular cancer	0.00254	0.00327	CcSEcCtD
Terlipressin—Cardiac disorder—Methotrexate—testicular cancer	0.00251	0.00323	CcSEcCtD
Terlipressin—Angiopathy—Methotrexate—testicular cancer	0.00245	0.00316	CcSEcCtD
Terlipressin—Nausea—Ifosfamide—testicular cancer	0.00241	0.00311	CcSEcCtD
Terlipressin—Diarrhoea—Cisplatin—testicular cancer	0.0024	0.00308	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—testicular cancer	0.00238	0.00307	CcSEcCtD
Terlipressin—Malnutrition—Methotrexate—testicular cancer	0.00235	0.00303	CcSEcCtD
Terlipressin—Cardiac disorder—Epirubicin—testicular cancer	0.00235	0.00302	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—testicular cancer	0.0023	0.00296	CcSEcCtD
Terlipressin—Vomiting—Cisplatin—testicular cancer	0.00223	0.00287	CcSEcCtD
Terlipressin—Malnutrition—Epirubicin—testicular cancer	0.0022	0.00284	CcSEcCtD
Terlipressin—Diarrhoea—Etoposide—testicular cancer	0.00219	0.00283	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—testicular cancer	0.00217	0.0028	CcSEcCtD
Terlipressin—Angiopathy—Doxorubicin—testicular cancer	0.00212	0.00274	CcSEcCtD
Terlipressin—Nausea—Cisplatin—testicular cancer	0.00208	0.00268	CcSEcCtD
Terlipressin—Vomiting—Etoposide—testicular cancer	0.00204	0.00263	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—testicular cancer	0.00204	0.00262	CcSEcCtD
Terlipressin—Headache—Etoposide—testicular cancer	0.00201	0.00259	CcSEcCtD
Terlipressin—Chest pain—Methotrexate—testicular cancer	0.002	0.00258	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00199	0.00256	CcSEcCtD
Terlipressin—Nausea—Etoposide—testicular cancer	0.0019	0.00245	CcSEcCtD
Terlipressin—Hypertension—Epirubicin—testicular cancer	0.0019	0.00245	CcSEcCtD
Terlipressin—Nervous system disorder—Methotrexate—testicular cancer	0.00188	0.00243	CcSEcCtD
Terlipressin—Chest pain—Epirubicin—testicular cancer	0.00188	0.00242	CcSEcCtD
Terlipressin—Skin disorder—Methotrexate—testicular cancer	0.00187	0.0024	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00186	0.0024	CcSEcCtD
Terlipressin—Nervous system disorder—Epirubicin—testicular cancer	0.00176	0.00227	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—testicular cancer	0.00176	0.00227	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—testicular cancer	0.00175	0.00226	CcSEcCtD
Terlipressin—Skin disorder—Epirubicin—testicular cancer	0.00175	0.00225	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—testicular cancer	0.00174	0.00223	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00172	0.00222	CcSEcCtD
Terlipressin—Dyspnoea—Methotrexate—testicular cancer	0.00171	0.00221	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00166	0.00214	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—testicular cancer	0.00163	0.0021	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—testicular cancer	0.00162	0.00209	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—testicular cancer	0.00162	0.00208	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—testicular cancer	0.0016	0.00206	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00155	0.002	CcSEcCtD
Terlipressin—Abdominal pain—Methotrexate—testicular cancer	0.00152	0.00196	CcSEcCtD
Terlipressin—Dyspnoea—Doxorubicin—testicular cancer	0.00148	0.00191	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00144	0.00185	CcSEcCtD
Terlipressin—Abdominal pain—Epirubicin—testicular cancer	0.00142	0.00183	CcSEcCtD
Terlipressin—Abdominal pain—Doxorubicin—testicular cancer	0.00131	0.00169	CcSEcCtD
Terlipressin—Diarrhoea—Methotrexate—testicular cancer	0.00131	0.00169	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—H2AFZ—testicular cancer	0.00128	0.00572	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STK11—testicular cancer	0.00127	0.00568	CbGpPWpGaD
Terlipressin—Diarrhoea—Epirubicin—testicular cancer	0.00123	0.00158	CcSEcCtD
Terlipressin—Vomiting—Methotrexate—testicular cancer	0.00122	0.00157	CcSEcCtD
Terlipressin—Headache—Methotrexate—testicular cancer	0.0012	0.00155	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—KITLG—testicular cancer	0.00118	0.00526	CbGpPWpGaD
Terlipressin—Vomiting—Epirubicin—testicular cancer	0.00114	0.00147	CcSEcCtD
Terlipressin—Nausea—Methotrexate—testicular cancer	0.00114	0.00147	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—testicular cancer	0.00114	0.00147	CcSEcCtD
Terlipressin—Headache—Epirubicin—testicular cancer	0.00113	0.00145	CcSEcCtD
Terlipressin—Nausea—Epirubicin—testicular cancer	0.00107	0.00138	CcSEcCtD
Terlipressin—Vomiting—Doxorubicin—testicular cancer	0.00106	0.00136	CcSEcCtD
Terlipressin—Headache—Doxorubicin—testicular cancer	0.00104	0.00134	CcSEcCtD
Terlipressin—Nausea—Doxorubicin—testicular cancer	0.000988	0.00127	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—H2AFZ—testicular cancer	0.000886	0.00396	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STK11—testicular cancer	0.000881	0.00394	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—H2AFZ—testicular cancer	0.000879	0.00393	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STK11—testicular cancer	0.000874	0.00391	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGFR3—testicular cancer	0.000874	0.00391	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KITLG—testicular cancer	0.000815	0.00365	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KITLG—testicular cancer	0.000809	0.00362	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KIT—testicular cancer	0.000802	0.00359	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGFR3—testicular cancer	0.000606	0.00271	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGFR3—testicular cancer	0.000601	0.00269	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KIT—testicular cancer	0.000556	0.00249	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KIT—testicular cancer	0.000552	0.00247	CbGpPWpGaD
